Skip to main content

IVD Contract Manufacturing Market to Surpass Valuation of USD 39.74 Billion by 2031 | SkyQuest Technology

The market expansion will be driven by the provision of diagnostic products to contracting organizations primarily due to the continued rise in healthcare costs, especially in emerging markets.

Westford, USA, Dec. 10, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global IVD contract manufacturing market size will reach a value of USD 39.74 Billion by 2031, with a CAGR of 11.60% during the forecast period (2024-2031). The healthcare industry’s rapid advancements are expected to propel the global market growth, and the growing need for quick and precise diagnostic testing has fuelled an increase in demand for in vitro diagnostics to enhance the speed and quality of patient care diagnosis, detection, and prevention. The increasing cases of chronic diseases, the demand for targeted treatment and the strict regulations are other factors boosting the growth of the market.

Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/ivd-contract-manufacturing-market

Browse in-depth TOC on the ” IVD Contract Manufacturing Market”

Pages – 194

Tables – 92

Figures – 67

IVD Contract Manufacturing Market Overview:

Report Coverage Details
Market Revenue in 2023USD 16.52 Billion
Estimated Value by 2031USD 39.74 Billion
Growth RatePoised to grow at a CAGR of 11.60%
Forecast Period2024–2031
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredProduct Type, Service Type, and Region
Geographies CoveredNorth America, Europe, Asia Pacific, Middle East & Africa, Latin America
Report HighlightsTransition to personalized medicine
Key Market OpportunitiesIncreasing demand for IVD devices
Key Market DriversTechnological advancement in IVD production

IVD Contract Manufacturing Market Segmental Analysis

Global IVD Contract Manufacturing Market is segmented into Product Type, Technology, Service Type, and region.

By Product Type, the market is classified into Consumables, and Equipment.

Depending on the Technology, it is categorized into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, and Other Technologies.

According to Service Type, the market is divided into Manufacturing Services, Assay Development, and Other Services.

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa. 

Consumables Product to Hold Significant Growth due to its Essential Role in Diagnostics and Point-of-Care Testing

Consumables hold a dominant share in the global IVD contract manufacturing market due to their essential role in diagnostics, driving constant demand. The expanding utilization of point-of-care testing, the growing incidence of chronic ailments, and the ability to perform tests multiple times are the factors contributing towards the utilization of reagents, kits, and other consumables. It contributes to the market expansion further strengthening the leadership of consumables, according to the global IVD contract manufacturing analysis market.

Immunoassays Technology to Lead Market due to High Accuracy and Sensitivity in Detecting Biomarkers

Immunoassays dominate the global IVD contract manufacturing market due to their high accuracy and sensitivity in detecting biomarkers. The mounting burden of chronic ailments and rising demand for tailor-made medicine are some of the factors underwriting the adoption of immunoassay-based testing. These factors propel the growth of the market further entrenching the dominance of immunoassays and setting a positive trajectory in the global IVD contract manufacturing market forecast.

For a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/ivd-contract-manufacturing-market

North America to Dominate Market due to Significant Research and Development Investments

The global IVD contract manufacturing market is primarily dominated by North America owing to better healthcare system, increased research and development expenditure, and high demand for the diagnostic tests. On the other hand, the stringent regulatory framework within the region coupled with the increasing chronic diseases helps in fuelling further growth in the market, cementing the North America region’s leadership in the global IVD contract manufacturing business market outlook.

IVD Contract Manufacturing Market Insight

Drivers:

  1. Increasing Incidences of Diabetes & Cancer
  2. Older Populations Require More Frequent Testing
  3. growing Preference for Quick & Reliable Testing at Home

Restraints:

  1. Challenges in Sourcing Raw Materials
  2. Protection of Proprietary Technology
  3. Slow Pace of Reimbursement

Prominent Players in IVD Contract Manufacturing Market

  • Jabil Inc.  
  •  Sanmina Corporation  
  •  TE Connectivity  
  •  Celestica, Inc.  
  •  West Pharmaceutical Services, Inc.  
  •  Savyon Diagnostics, Ltd.  
  •  KMC Systems  
  •  Cenogenics Corporation  
  •  Nova Biomedical  
  •  Cone Bioproducts  
  •  Kimball Electronics, Inc.  
  • Roche Diagnostics  
  •  Viant Medical Holdings, Inc.  
  • Sysmex Corporation  
  •  Stratec Se  
  •  Thermo Fisher Scientific, Inc.  
  •  Fujirebio  
  •  Biokit (Werfen)  
  •  Sekisui  
  •  Prestige Diagnostics

Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/ivd-contract-manufacturing-market

Key Questions Answered in Global IVD Contract Manufacturing Market Report

  • What is the projected market size of the global IVD contract manufacturing industry by 2031?
  • Which region is expected to dominate the market?
  • What are the key factors driving the growth of the market?

This report provides the following insights:

Analysis of key drivers (Increased spending on healthcare infrastructure, faster approvals for IVD products, shift toward precision medicine increases), restraints (Environmental footprint of producing diagnostic devices, risks related to quality & supply continuity) opportunities (Rise of targeted therapies, increasing use of genetic testing) influencing the growth of IVD contact manufacturing market.

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the IVD contract manufacturing market.
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the IVD contract manufacturing market.
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

To read the full report, please visit: https://www.skyquestt.com/report/ivd-contract-manufacturing-market

Related Reports:

Stem Cell Banking Market Set to Grow at 18.30% CAGR Through 2031

Protein A Resin Market Set to Grow at 9.81% CAGR Through 2031

Transradial Access Devices Market Set to Grow at 7.81% CAGR Through 2031

Onychomycosis Treatment Market Set to Grow at 8.60% CAGR Through 2031

Medical Radiation Shielding Market Set to Grow at 6.52% CAGR Through 2031

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia-Pacific.

Contact:

Mr. Jagraj Singh

SkyQuest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.